October 15, 2014

Sanofi US announced Wednesday the findings of a new survey that reveals striking differences in opinion among various age groups about diabetes and available treatment options.

October 14, 2014

Healthgrades on Monday announced the launch of its new Cold and Flu Center at http://www.healthgrades.com/right-care/cold-and-flu/.

October 14, 2014

The Pharmaceutical Research and Manufacturers of America on Tuesday launched AccessBetterCoverage.org.

 

October 10, 2014

The Food and Drug Administration on Friday approved Akynzeo (netupitant and palonosetron) for the treatment of nausea and vomiting in patients who are undergoing cancer chemotherapy.

October 10, 2014

The Food and Drug Administration on Friday approved Gilead's Harvoni (ledipasvir and sofosbuvir) to treat chronic hepatitis C virus genotype 1 infection.

October 10, 2014

The Drug Enforcement Administration’s final rule moving hydrocodone combination products from Schedule III to the more-restrictive Schedule II officially went into effect on Monday. 

October 9, 2014

Endo International and Auxilium Pharmaceuticals on Thursday announced that they have entered into a definitive agreement.

October 9, 2014

Purdue Pharma on Thursday announced the launch of a new dosage strength of 7.5 mcg/hour for its Butrans (buprenorphine) transdermal system CIII, bringing the total number of strengths offered by the company to five.

October 9, 2014

Salix Pharmaceuticals on Thursday announced that the Food and Drug Administration granted final approval for the company's Uceris (budesonide) rectal foam for patients with mild-to-moderate distal ulcerative colitis. 

October 8, 2014

The Pharmaceutical Research and Manufacturers of America on Tuesday released a new report highlighting the number of investigational cancer medicines that did not succeed in clinical trials. 

October 8, 2014

Boehringer Ingelheim on Wednesday announced that its Striverdi Respimat (olodaterol) inhalation spray in 5-mcg dosage strength is now available by prescription in pharmacies across the United States. 

October 8, 2014

Teva Pharmaceutical Industries on Wednesday announced the initiation of a rolling new drug application submission for hydrocodone bitartrate extended-release tablets.

October 7, 2014

Actavis and Durata Therapeutics on Monday announced that they have entered into a definitive merger agreement.

October 7, 2014

America’s biopharmaceutical research companies are currently developing nearly 800 new medicines and vaccines for cancer, according to a new PhRMA report.

 

October 6, 2014

Seven influenza vaccine manufacturers projected that as many as 151 million to 159 million doses of influenza vaccine will be available for use in the United States.

October 6, 2014

Specialty drug spending continues to rise and is predicted to grow by more than 16% annually from 2015 to 2018. CVS Health researchers examine the reasons for such dramatic increases in spending and discuss tools to help manage these escalating costs.

October 6, 2014

Healthcare Distribution Management Association released a statement in support of the FDA’s “Know Your Source” campaign.

October 6, 2014

Sam’s Club is making vaccinations as affordable as possible by matching the price of any competitor with their low price promise.

October 3, 2014

In celebration of all that they do, October is designated as American Pharmacists Month. Drug Store News wants to hear from you! Have you had a pharmacist that went above and beyond to help?

October 2, 2014

Walgreens on Thursday announced a first-of-its-kind partnership with the Department of Veterans Affairs to improve care coordination and integrate immunization records for more than 8.5 million VA-enrolled patients.

October 1, 2014

Protein Sciences Corp. on Monday announced today that doses of its Flublok influenza vaccine have been released and are now available for shipment.

October 1, 2014

Ranbaxy Labs on Wednesday announced the launch of Absorica (isotretinoin) 25 mg and 35 mg capsules into the U.S. healthcare market. 

September 30, 2014

Johnson & Johnson on Tuesday announced a definitive agreement to acquire Alios BioPharma, a privately held clinical stage biopharmaceutical company focused on developing therapies for viral diseases, for approximately $1.8 billion in cash.

September 30, 2014

Salix Pharmaceuticals and Progenics Pharmaceuticals announced that the Food and Drug Administration approved Relistor (methylnaltrexone bromide) subcutaneous injection in 12-mg dosage strength to treat constipation in patients taking opioids for chronic, non-cancer pain.